BridgeBio Pharma, Inc. To Present At Upcoming Investor Conference

Rhea-AI Summary

BridgeBio Pharma (Nasdaq: BBIO) will present at the Bank of America Securities 2020 Health Care Conference on May 14, 2020, at 11 AM ET. The presentation will be accessible via a live webcast on the company’s investor page, with a replay available until August 12, 2020. Founded in 2015, BridgeBio focuses on developing transformative medicines for genetic diseases and cancers with genetic drivers. The company boasts a robust pipeline of over 20 development programs, ranging from early discovery to late-stage development.

PALO ALTO, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced today that it will present at the Bank of America Securities 2020 Health Care Conference on Thursday, May 14, 2020 at 11 AM (ET).

The presentation will be webcast live and can be accessed at www.bridgebio.com on the For Investors page under News & Events. The webcast will be available for replay through August 12, 2020.

About BridgeBio
BridgeBio is a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio’s pipeline of over 20 development programs includes product candidates ranging from early discovery to late-stage development.

Investor Contact:
John Grimaldi, Burns McClellan
jgrimaldi@burnsmc.com
212-213-0006 ext. 362

Media contact:
BridgeBio Pharma, Inc.
Grace Rauh
Grace.rauh@bridgebio.com
(917) 232-5478

Source: BridgeBio Pharma, Inc.

FAQ

What date will BridgeBio Pharma present at the Health Care Conference?

BridgeBio Pharma will present on May 14, 2020.

What time is BridgeBio Pharma's presentation scheduled for?

The presentation is scheduled for 11 AM ET.

Where can I access the webcast of BridgeBio Pharma's presentation?

The webcast can be accessed on BridgeBio's investor page.

Until when will the presentation be available for replay?

The presentation can be replayed until August 12, 2020.

What focus areas does BridgeBio Pharma specialize in?

BridgeBio specializes in medicines for genetic diseases and cancers with clear genetic drivers.

How many development programs does BridgeBio Pharma have?

BridgeBio has over 20 development programs.